UPDATE: Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countriesMarket Watch • 11/16/21
Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countriesMarket Watch • 11/16/21
Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income CountriesBusiness Wire • 11/16/21
Imugene secures clinical trial supply agreement with Merck KGaA and Pfizer for HER-Vaxx gastric cancer trialProactive Investors • 11/15/21
Pfizer's Premier COVID Franchise Lays The Foundation For Continued Outsized ReturnsSeeking Alpha • 11/12/21
Pfizer Stock: How Will Recent Earnings Results Impact The Stock Going ForwardSeeking Alpha • 11/10/21